Abbott Laboratories Com Stk NPV (NYSE:ABT)
| CAPS Rating |
|
|---|---|
| Open | $55.48 |
| Previous Close | $55.57 |
| Daily Range | $54.99 - $55.60 |
| 52-Week Range | $45.28 - $56.84 |
| Market Cap | $85.83B |
| P/E Ratio | 16.10 |
| Dividend (Yield) | 1.92 (2.90%) |
| Volume | 2,662,548 |
| Average Daily Volume | 0 |
ABT
VS S&P 500 (SPY)
How do you think ABT will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ABT Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ABT News and Commentary
- Abbott Labs: 2 for the price of 1 – Blog at The Motley Fool
- CIVETS Watch: US Dollar Is Popular in Egypt, but US Is Not – Minyanville
- YCHARTS DIVIDEND DAILY: Some “Non-Royalty” Dividends Beat the Aristocrats – YCharts
- Make Money in Growing Health Care Stocks the Easy Way – The Motley Fool
- Another Reason to Worry About Profits: Uncle Sam is Propping Them Up With Tax Breaks – YCharts
- Is This Situation Special Enough? – The Motley Fool
- Dividend Stocks You Need to Watch Today – The Motley Fool
- Three Stocks for the Dividend Craze – Minyanville
- How to Stop “Off-Label” Marketing and Sales of Prescription Drugs – NASDAQ
- How to Stop “Off-Label” Marketing and Sales of Prescription Drugs – Trefis
- The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth – Trefis
- The Best Yielding Healthcare Dividend Stocks With Fastest Earnings Growth – Blog at The Motley Fool
- Here's the Problem With Abbott Laboratories – The Motley Fool
- Amgen Misses; 2012 Outlook Strong - Analyst Blog – NASDAQ
- Hang Tight: This Bid Will Increase – The Motley Fool
- Will These 5 Stocks Tumble In 2012? – Blogs @ The Motley Fool
- Abbott Laboratories Beats Estimates Yet Again – The Motley Fool
- Screen for Winning Stocks – The Motley Fool
- UPDATE: Abbott Labs 4Q Net Rises 12%; Sales Miss Views – SmartMoney
- Abbott Labs 4Q Net Rises 12%, Margins Improve; Sales Miss Views – SmartMoney
RSS Headlines
Fool UK
